BioCentury
ARTICLE | Company News

King submits Theelin NDA

October 31, 2001 8:00 AM UTC

KG submitted an NDA to the FDA for Theelin injectable estrogen replacement therapy to treat moderate to severe vasomotor symptoms of menopause, and vaginal and vulvar atrophy. ...